These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 4128605)

  • 1. Letter: Radioimmunoassay of cholecystokinin-pancreozymin.
    Bloom SR
    Lancet; 1973 Dec; 2(7840):1272-3. PubMed ID: 4128605
    [No Abstract]   [Full Text] [Related]  

  • 2. Hormonal content and effect on gallbladder of commercial preparations of cholecystokinin-pancreozymin.
    Harvey RF; Oliver JM
    Horm Metab Res; 1981 Aug; 13(8):446-50. PubMed ID: 7327522
    [No Abstract]   [Full Text] [Related]  

  • 3. How does cholecystokinin contract the gallbladder?
    Krevsky B
    Gastroenterology; 1992 Aug; 103(2):706-8. PubMed ID: 1634088
    [No Abstract]   [Full Text] [Related]  

  • 4. A multiparameter study on the action of preparations containing cholecystokinin-pancreozymin.
    Brown JC; Pederson RA
    Scand J Gastroenterol; 1970; 5(6):537-41. PubMed ID: 4918420
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of equimolar amounts of long-chain triglycerides and medium-chain triglycerides on plasma cholecystokinin and gallbladder contraction.
    Hopman WP; Jansen JB; Rosenbusch G; Lamers CB
    Am J Clin Nutr; 1984 Mar; 39(3):356-9. PubMed ID: 6695835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholecystokinin receptor antagonist loxiglumide: influence on bilio-pancreatic secretion and gastrointestinal hormones in man.
    Schmidt WE; Creutzfeldt W; Höcker M; Choudhury AR; Nustede R; Schleser A; Nitsche R; Rovati LC; Schafmayer A; Fölsch UR
    Digestion; 1990; 46 Suppl 2():232-9. PubMed ID: 2262057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of increasing oral doses of loperamide on gallbladder motility in man.
    Hopman WP; Rosenbusch G; Jansen JB; Lamers CB
    Br J Clin Pharmacol; 1990 Jan; 29(1):55-60. PubMed ID: 2297461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo contractility of smooth muscle by cholecystokinin concentrates.
    Denton RW; Gershbein LL
    Arch Int Pharmacodyn Ther; 1967 Apr; 166(2):473-85. PubMed ID: 6067893
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of chlorpromazine on cholecystokinin induced gallbladder contraction.
    Pomeranz IS; Davison JS; St George C; Shaffer EA
    Proc West Pharmacol Soc; 1987; 30():211-3. PubMed ID: 3628280
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of substance P on contractions of the gallbladder.
    Mate L; Sakamoto T; Greeley GH; Thompson JC
    Surg Gynecol Obstet; 1986 Aug; 163(2):163-6. PubMed ID: 2426812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coffee stimulation of cholecystokinin release and gallbladder contraction in humans.
    Douglas BR; Jansen JB; Tham RT; Lamers CB
    Am J Clin Nutr; 1990 Sep; 52(3):553-6. PubMed ID: 2393014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin inhibits cholecystokinin-induced contraction of isolated gallbladder smooth muscle cells.
    Yamasaki T; Chijiiwa K; Chijiiwa Y
    J Surg Res; 1995 Dec; 59(6):743-6. PubMed ID: 8538175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differing sensitivities of gallbladder and pancreas to cholecystokinin-pancreozymin (CCK-PZ) in man.
    Malagelada JR; Go VL; Summerskill WH
    Gastroenterology; 1973 May; 64(5):950-4. PubMed ID: 4700421
    [No Abstract]   [Full Text] [Related]  

  • 14. Motor interaction between cimetidine and cholecystokinin-related peptides in the gall bladder.
    Stasiewicz J; Szałaj W; Gabryelewicz A
    Pol J Pharmacol Pharm; 1980; 32(5):643-6. PubMed ID: 7267456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibition by somatostatin of pancreatic juice and enzyme secretion and gallbladder contraction in man induced by secretin and cholecystokinin-pancreozymin administration (author's transl)].
    Creutzfeldt W; Lankisch PG; Fölsch UR
    Dtsch Med Wochenschr; 1975 May; 100(20):1135-8. PubMed ID: 1126301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of [27-Tyr]-cholecystokinin-pancreozymin (CCK-PZ).
    Yajima H; Mori Y; Kiso Y; Koyama K; Tobe T; Setoyama M; Adachi H; Kanno T; Saito A
    Chem Pharm Bull (Tokyo); 1976 May; 24(5):1110-3. PubMed ID: 1021264
    [No Abstract]   [Full Text] [Related]  

  • 17. Distribution of cholecystokinin activity in the rat small intestine.
    Schneeman BO; Lyman RL
    Digestion; 1977; 15(1):28-33. PubMed ID: 838175
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of C-terminal octapeptide of cholecystokinin in cholecystography.
    Levant JA; Sturdevant RA
    Am J Roentgenol Radium Ther Nucl Med; 1974 Jun; 121(2):380-3. PubMed ID: 4846559
    [No Abstract]   [Full Text] [Related]  

  • 19. [Behavior of secretin-pancreozymin-stimulated pancreatic secretion, gallbladder contraction and choleresis after somatostatin administration].
    von Kleist D; Zschiedrich M; Stopik D; Hampel KE
    Dtsch Z Verdau Stoffwechselkr; 1981; 41(5):219-24. PubMed ID: 6173190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of adrenergic system on cholecystokinin action within isolated guinea-pig gallbladder (author's transl)].
    Stasiewicz J; Szalaj W; Gabryelewicz A
    Przegl Lek; 1975; 32(9):716-9. PubMed ID: 1188137
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.